Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.

Kraus, V B; Burnett, B; Coindreau, J; Cottrell, S; Eyre, D; Gendreau, M; Gardiner, J; Garnero, P; Hardin, J; Henrotin, Y; Heinegård, D; Ko, A; Lohmander, L S; Matthews, G; Menetski, J; Moskowitz, R; Persiani, S; Poole, A R; Rousseau, J-C; Todman, M

Kraus, V B; Burnett, B; Coindreau, J; Cottrell, S; Eyre, D; Gendreau, M; Gardiner, J; Garnero, P; Hardin, J; Henrotin, Y; Heinegård, D; Ko, A; Lohmander, L S; Matthews, G; Menetski, J; Moskowitz, R; Persiani, S; Poole, A R; Rousseau, J-C; Todman, M.

Affiliation

Kraus VB; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. vbk@duke.edu

Osteoarthritis Cartilage ; 19(5): 515-42, 2011 May.

Article in En | MEDLINE | ID: mdl-21396468

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis / Biomarkers / Drug Discovery Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Osteoarthritis Cartilage Journal subject: ORTOPEDIA / REUMATOLOGIA Year: 2011 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google